We subsequently tested whether digoxin (shown to inhibit IL-17A production [35] and possibly tumour metastasis [36]) and SR1001 (described to impede the differentiation and function of TH17 cells [35, 37]) could reduce LRV1 mediated disease severity in our murine model. The gene discussed is IL17A; the disease is neoplasm.